Innovacell
Blood & Organ Banks · Austria · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Mitterweg 24, Innsbruck, Tyrol, 6020, Au...Phone Number
+43 512573680Website
www.innovacell.atRevenue
$6.8 MillionIndustry
About Innovacell
Is Innovacell your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Innovacell has new funding data
Check out if Innovacell is spiking on competitors!
Earning: See what the market has to say on Innovacell recently announced quarterly report
Click to see if Innovacell had a recent Job posting/layoffs
Product Launch: Get notified when Innovacell launches new products
Innovacell, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Innovacell has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Innovacell
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Innovacell is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Innovacell is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Innovacell.
Innovacell Tech Stack
A closer look at the technologies used by Innovacell
Innovacell News & Media
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Innovacell
Innovacell Inc. is a regenerative medicine and cell therapy company headquartered in Tokyo, Japan. Founded in January 2021, the company focuses on the development and manufacture of regenerative medical products targeting fecal and urinary incontinence. Utilizing a global aggregation model, the company identifies promising cell therapy seeds worldw... Read More